Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021 | Zendy

Maureen J. Miller | Zendy; Austin Himschoot | Zendy; Natalie Fitch | Zendy; Sucheta Jawalkar | Zendy; Dane F. Freeman | Zendy; Charity Hilton | Zendy; Kevin Berney | Zendy; Gery P. Guy | Zendy; Tina J. Benoit | Zendy; Kristie E.N. Clarke | Zendy; Michael P. Busch | Zendy; Jean D. Opsomer | Zendy; Susan L. Stramer | Zendy; Aron J. Hall | Zendy; Adi V. Gundlapalli | Zendy; Adam MacNeil | Zendy; Russell F. McCord | Zendy; Gregory Sunshine | Zendy; Mara Howard-Williams | Zendy; Christopher Dunphy | Zendy; Jefferson M. Jones | Zendy

Open Access

Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021

Author(s) -

Maureen J. Miller,

Austin Himschoot,

Natalie Fitch,

Sucheta Jawalkar,

Dane F. Freeman,

Charity Hilton,

Kevin Berney,

Gery P. Guy,

Tina J. Benoit,

Kristie E.N. Clarke,

Michael P. Busch,

Jean D. Opsomer,

Susan L. Stramer,

Aron J. Hall,

Adi V. Gundlapalli,

Adam MacNeil,

Russell F. McCord,

Gregory Sunshine,

Mara Howard-Williams,

Christopher Dunphy,

Jefferson M. Jones

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac469

Subject(s) - medicine , covid-19 , psychological intervention , betacoronavirus , seroprevalence , coronavirus , coronavirus infections , respiratory system , severe acute respiratory syndrome coronavirus , intensive care medicine , virology , immunology , outbreak , disease , psychiatry , antibody , serology , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research